<DOC>
	<DOCNO>NCT01543412</DOCNO>
	<brief_summary>No validated second-line chemotherapy treatment locally advanced/metastatic pancreatic cancer actually available , failure gemcitabine ( +/- Cisplatin Oxaliplatin ) -based regimen . Irinotecan seem moderately active drug treatment disease Recently report interesting result use potentially non -cross resistant regimen ( FOLFIRI ) could useful even second-line chemotherapy . An exploratory study set seem warrant .</brief_summary>
	<brief_title>Second Line Chemotherapy Advanced Pancreatic Cancer</brief_title>
	<detailed_description />
	<mesh_term>Adenocarcinoma</mesh_term>
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<criteria>Signed write informed consent prior begin protocol specific procedure Previous chemotherapy Gemcitabine plus less Platinoids Previous gemcitabine deliver radiosensitizer locally advanced disease , follow gemcitabine plus less platinoids maintenance disease progression allow . Male female less 75 year age Diagnosis histologically cytologically confirm adenocarcinoma pancreas Locally advance ( nonresectable ) metastatic pancreatic cancer Presence least one unidimensional indicator lesion measurable CT scan MRI irradiate area ECOG performance status 0 1 study entry Life expectancy : 3 month Neutrophils 1.5 x 109L , platelet 100 x 109L , hemoglobin 10 gdL Bilirubin level either normal less 1.5 x ULN ASAT ALAT normal less 2.5 x ULN ( normal less 5 x ULN liver metastasis present ) Serum creatinine le 1.5 x ULN Amylase normal less 1.5 ULN Effective contraception male female patient risk conception exists Absence psychological , familial , sociological geographical condition potentially hamper compliance study protocol followup schedule ; condition assess patient registration trial Brain metastases Previous treatment irinotecan fluoropyrimidines Significant cardiovascular disease : clinically relevant coronary artery disease history myocardial infarction within last 6 month Significant gastrointestinal abnormality Gilbert 's Syndrome Any uncontrolled infection Known HIV infection Radiotherapy within 4 week prior study entry Any investigational agent 4 week prior entry Known grade 3 4 allergic reaction component treatment Known drug abuse alcohol abuse Medical psychological condition opinion investigator would permit patient complete study sign meaningful inform consent Women pregnant breastfeed Any concurrent malignancy nonmelanoma skin cancer , carcinoma situ cervix . Legal incapacity limit legal capacity</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>FOLFIRI</keyword>
	<keyword>Metastases</keyword>
	<keyword>pancreatic adenocarcinoma</keyword>
	<keyword>locally advanced metastatic pancreatic adenocarcinoma</keyword>
</DOC>